2012-10-10 01:10:21 - Fast Market Research recommends "Avanti Therapeutics - Product Pipeline Review - 2012" from Global Markets Direct, now available

Global Market Direct's pharmaceuticals report, "Avanti Therapeutics - Product Pipeline Review - 2012" provides data on the Avanti Therapeutics's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Avanti Therapeutics's corporate website, SEC filings, investor presentations and featured press releases, both from Avanti Therapeutics and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468509_avanti_therapeutics_product_pipeline_ ..


Scope

* Avanti Therapeutics - Brief Avanti Therapeutics overview including business description, key information and facts,

and its locations and subsidiaries.
* Review of current pipeline of Avanti Therapeutics human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Avanti Therapeutics with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Avanti Therapeutics's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate Avanti Therapeutics's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Avanti Therapeutics in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Avanti Therapeutics's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Avanti Therapeutics.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Avanti Therapeutics and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Avanti Therapeutics Snapshot
Avanti Therapeutics Overview
Key Information
Key Facts
Avanti Therapeutics - Research and Development Overview
Key Therapeutic Areas
Avanti Therapeutics - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Avanti Therapeutics - Pipeline Products Glance
Avanti Therapeutics - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Avanti Therapeutics - Drug Profiles
ATAD-371
Product Description
Mechanism of Action
R&D Progress
ATAD-375
Product Description
Mechanism of Action
R&D Progress
ATAD-437
Product Description
Mechanism of Action
R&D Progress
ATAD-624
Product Description
Mechanism of Action
R&D Progress
ATAI-537
Product Description
Mechanism of Action
R&D Progress
ATAI-543
Product Description
Mechanism of Action
R&D Progress
ATAPD-617
Product Description
Mechanism of Action
R&D Progress
ATAS-123
Product Description
Mechanism of Action
R&D Progress
ATBB-239
Product Description
Mechanism of Action
R&D Progress
ATBR-279
Product Description
Mechanism of Action
R&D Progress
ATCB-468
Product Description
Mechanism of Action
R&D Progress
ATIF-326
Product Description
Mechanism of Action
R&D Progress
ATML-147
Product Description
Mechanism of Action
R&D Progress
ATMS-543
Product Description
Mechanism of Action
R&D Progress
ATND-146
Product Description
Mechanism of Action
R&D Progress
ATND-273
Product Description
Mechanism of Action
R&D Progress
ATTR-416
Product Description
Mechanism of Action
R&D Progress
CT-AS-227
Product Description
Mechanism of Action
R&D Progress
CT-BT-316
Product Description
Mechanism of Action
R&D Progress
CT-GI-745
Product Description
Mechanism of Action
R&D Progress
CT-HN-674
Product Description
Mechanism of Action
R&D Progress
CT-KT-124
Product Description
Mechanism of Action
R&D Progress
CT-LC-583
Product Description
Mechanism of Action
R&D Progress
CT-PC-348
Product Description
Mechanism of Action
R&D Progress
CT-PC-434
Product Description
Mechanism of Action
R&D Progress
Avanti Therapeutics - Pipeline Analysis
Avanti Therapeutics - Pipeline Products by Therapeutic Class
Avanti Therapeutics - Pipeline Products By Mechanism of Action
Avanti Therapeutics - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Avanti Therapeutics, Key Information
Avanti Therapeutics, Key Facts
Avanti Therapeutics - Pipeline by Indication, 2012
Avanti Therapeutics - Pipeline by Stage of Development, 2012
Avanti Therapeutics - Monotherapy Products in Pipeline, 2012
Avanti Therapeutics - Pre-Clinical, 2012
Avanti Therapeutics - Pipeline By Therapeutic Class, 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468509&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.